(3S,5S)-3-异丙基-2-氧代-5-[(2S,4S)-四氢-4-异丙基-5-氧代-2-呋喃基]-1-吡咯烷羧酸叔丁酯结构式
|
常用名 | (3S,5S)-3-异丙基-2-氧代-5-[(2S,4S)-四氢-4-异丙基-5-氧代-2-呋喃基]-1-吡咯烷羧酸叔丁酯 | 英文名 | (3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester |
---|---|---|---|---|
CAS号 | 934841-17-5 | 分子量 | 353.45300 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C19H31NO5 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
中文名 | (3S,5S)-3-异丙基-2-氧代-5-[(2S,4S)-四氢-4-异丙基-5-氧代-2-呋喃基]-1-吡咯烷羧酸叔丁酯 |
---|---|
英文名 | tert-butyl (3S,5S)-2-oxo-5-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate |
英文别名 | 更多 |
分子式 | C19H31NO5 |
---|---|
分子量 | 353.45300 |
精确质量 | 353.22000 |
PSA | 72.91000 |
LogP | 3.32020 |
~% (3S,5S)-3-异丙基-2... 934841-17-5 |
文献:NOVARTIS AG; NOVARTIS PHARMA GmbH Patent: WO2007/45420 A2, 2007 ; Location in patent: Page/Page column 63-64 ; |
~% (3S,5S)-3-异丙基-2... 934841-17-5 |
文献:NOVARTIS AG Patent: WO2008/119804 A1, 2008 ; Location in patent: Page/Page column 61-62 ; WO 2008/119804 A1 |
(3S,5S)-3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydro-furan-2-yl)-2-oxopyrrolidine-1-carboxylic acid tert-butyl ester |
(3S,5S)-3-(1-Methylethyl)-2-oxo-5-[(2S,4S)-tetrahydro-4-(1-methylethyl)-5-oxo-2-furanyl]-1-pyrrolidinecarboxylic acid tert-butyl ester |
(3S,5S)-tert-Butyl 3-isopropyl-5-((2S,4S)-4-isopropyl-5-oxotetrahydrofuran-2-yl)-2-oxopyrrolidine-1-carboxylate |